Dr. Leung Kwok Chuen Dennis - Clinical Oncology
Specialist in Clinical Oncology
Highlights
- MCHK RegisteredVerified
- Specialist in Clinical OncologyBachelor of Medicine and Bachelor of Surgery (MBBS) · Hong Kong College of Radiologists · Medical degree 1997
- InsuranceBeing compiled｜See details
About
Dr. Leung Kwok Chuen Dennis is a registered Clinical Oncology specialist in Hong Kong.
Education
Specialist in Clinical Oncology
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)1997
Hong Kong Academy of Medicine fellowships
- FHKCRFellow, Hong Kong College of Radiologists
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Leung Kwok Chuen Dennis? Claim page and update insurance →
FAQ
Is Dr. Leung Kwok Chuen Dennis any good?
Dr. Leung Kwok Chuen Dennis is a registered Clinical Oncology specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Leung Kwok Chuen Dennis do?
Dr. Leung Kwok Chuen Dennis practises in Clinical Oncology.
Are you Dr. Leung Kwok Chuen Dennis? Claim this page to update and manage.
ClaimResearch and publications
8 papers
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Lymphocyte nadir and recovery dynamics for locally advanced thoracic malignancies undergoing concurrent chemo-irradiation: Establishment of organs-at-risk constraints.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2025
- The diagnostic accuracy of next-generation sequencing in advanced NSCLC.The journal of liquid biopsy · 2025
- Role of Circulating Tumor DNA Tumor Fraction in Advanced Non-Small Cell Lung Cancer and Its Impact on Patient Treatment Outcomes: A Prospective Real-World Study.JCO precision oncology · 2025
- Anaplastic Lymphoma Kinase (ALK) Fusion as a Resistance Mechanism to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors With Complete Response After Osimertinib and Alectinib: A Case Report and Literature Review.Cureus · 2025
- Stereotactic Body Radiotherapy and Liver Transplant for Liver Cancer: A Nonrandomized Controlled Trial.JAMA network open · 2024
- The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification.International journal of cancer · 2019
- The prevalence and impact of cervical spine pathologies in patients with nasopharyngeal carcinoma.Oral oncology · 2019
- Prognostication of serial post-intensity-modulated radiation therapy undetectable plasma EBV DNA for nasopharyngeal carcinoma.Oncotarget · 2017
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer